It is commonly believed that prostate cancer patients with very high prostate-specific antigen(PSA) levels are unlikely to benefit from definitive local treatment,and patients with very high PSA are often underrepresented in randomized clinical trials.A registry-based analysis of 6449 patients without ...
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
aRecently, Lilja et al (130) demonstrated a very strong association between PSA levels in blood collected more than 20 years prior to prostate cancer diagnosis and the likelihood of that diagnosis in a large representative population of[translate]...
Diagram of Study Cohort View LargeDownload M1 indicates bone metastases; NCCN, National Comprehensive Cancer Network; PSA, prostate-specific antigen. Figure 2. Overall Survival of Patients Treated at High vs Low Average Cumulative Facility Radiation Volume Centers View LargeDownload Unadjusted (A) and ...
Despite state of the art local therapy, a significant portion of men with high-risk prostate cancer develop progressive disease. Neoadjuvant systemic thera... RR Mckay,TK Choueiri,ME Taplin - 《Drugs》 被引量: 34发表: 2013年 PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong ...
For instance elevated PSA predicts prostate cancer only 20% of the time. Additional biomarker的证明为多数癌症是非常困难的。 当前为多数癌症,没有biomarker可利用。 为那些biomarkers被辨认了的地方, biomarkers有非常恶劣的预计值。 例如高的PSA预言时间的摄护腺癌仅20%。 另外,当肿瘤进步,一特定biomarker变得...
BT-boost showed no benefit over modern DeRT in the patients with VHR. Abstract This study examined the role of brachytherapy boost (BT-boost) and external beam radiotherapy (EBRT) in intermediate- to high-risk prostate cancer, especially in patients with very high-risk factors (VHR: T3b–4 ...
That intensity-modulated radiotherapy (IMRT) plus antiandrogen therapy (IMRT-ADT) and radical prostatectomy (RP) are the definitive optimal treatments for relatively young patients (aged ≤ 65 years) with high- or very high-risk localized prostate cancer (HR/VHR-LPC), but remains controversial. ...
There are different kinds of thyroid cancer, depending upon the specific cell type within the thyroid that has become cancerous. Most cases of thyroid cancer have a good prognosis and high survival rates, especially when diagnosed in its early stages. Health News Many Women With Epilepsy Unaware...
Parker Highlander PLLC (Austin, TEXAS, US) Parent Case Data: CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Patent Application No. 62/155,999, filed May 1, 2015, the entirety of which is incorporated herein by reference. ...